2159 — Mediwelcome Healthcare Management & Technology Balance Sheet
0.000.00%
- HK$347.20m
- HK$302.82m
- CNY321.56m
- 44
- 20
- 60
- 34
Annual balance sheet for Mediwelcome Healthcare Management & Technology, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 105 | 175 | 154 | 80.4 | 71.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 79.2 | 85.4 | 78 | 73 | 51.7 |
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 203 | 275 | 251 | 181 | 161 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 29.5 | 24.4 | 15.4 | 10.7 | 11.5 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 280 | 367 | 318 | 214 | 194 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 85.4 | 57.3 | 108 | 92.3 | 117 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 119 | 83.6 | 123 | 98.2 | 123 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 161 | 283 | 195 | 116 | 71.1 |
| Total Liabilities & Shareholders' Equity | 280 | 367 | 318 | 214 | 194 |
| Total Common Shares Outstanding |